17-35879999-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP5BP4BA1
The NM_001278736.2(CCL5):c.76+231T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.162 in 152,178 control chromosomes in the GnomAD database, including 2,242 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: 𝑓 0.16 ( 2242 hom., cov: 32)
Consequence
CCL5
NM_001278736.2 intron
NM_001278736.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.569
Genes affected
CCL5 (HGNC:10632): (C-C motif chemokine ligand 5) This gene is one of several chemokine genes clustered on the q-arm of chromosome 17. Chemokines form a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of the N-terminal cysteine residues of the mature peptide. This chemokine, a member of the CC subfamily, functions as a chemoattractant for blood monocytes, memory T helper cells and eosinophils. It causes the release of histamine from basophils and activates eosinophils. This cytokine is one of the major HIV-suppressive factors produced by CD8+ cells. It functions as one of the natural ligands for the chemokine receptor chemokine (C-C motif) receptor 5 (CCR5), and it suppresses in vitro replication of the R5 strains of HIV-1, which use CCR5 as a coreceptor. Alternative splicing results in multiple transcript variants that encode different isoforms. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PP5
Variant 17-35879999-A-G is Pathogenic according to our data. Variant chr17-35879999-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 12740.Status of the report is no_assertion_criteria_provided, 0 stars.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86). . Strength limited to SUPPORTING due to the PP5.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.317 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCL5 | NM_002985.3 | c.76+231T>C | intron_variant | ENST00000605140.6 | |||
LOC105371745 | XR_007065724.1 | n.148-4383A>G | intron_variant, non_coding_transcript_variant | ||||
CCL5 | NM_001278736.2 | c.76+231T>C | intron_variant | ||||
LOC105371745 | XR_934699.2 | n.148-4383A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCL5 | ENST00000605140.6 | c.76+231T>C | intron_variant | 5 | NM_002985.3 | P1 | |||
ENST00000605548.1 | n.153-4383A>G | intron_variant, non_coding_transcript_variant | 3 | ||||||
CCL5 | ENST00000605509.2 | c.76+231T>C | intron_variant | 3 | P1 | ||||
CCL5 | ENST00000651122.1 | c.76+231T>C | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.162 AC: 24682AN: 152060Hom.: 2229 Cov.: 32
GnomAD3 genomes
AF:
AC:
24682
AN:
152060
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.162 AC: 24726AN: 152178Hom.: 2242 Cov.: 32 AF XY: 0.163 AC XY: 12153AN XY: 74398
GnomAD4 genome
AF:
AC:
24726
AN:
152178
Hom.:
Cov.:
32
AF XY:
AC XY:
12153
AN XY:
74398
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
690
AN:
3478
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Human immunodeficiency virus type 1, rapid disease progression with infection by Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 23, 2002 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at